Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

3.07 0.04 (1.32%)

12-11 10:04

Open:

3.04

Pre. Close:

3.03

High:

3.0893

Low:

3.03

Volume:

208,908

Market Cap:

417M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.08 - 3.13

3.13 - 3.19

Low:

2.85 - 2.89

2.89 - 2.94

Close:

2.96 - 3.04

3.04 - 3.13

Technical analysis  (as of: 2017-12-08 4:55:31 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 3.56     One year: 4.16

Support:

Support1: 2.62    Support2: 2.35

Resistance:

Resistance1: 3.05    Resistance2: 3.56

Pivot:

2.92

Moving Averages:

MA(5): 2.92     MA(20): 2.88

MA(100): 2.67     MA(250): 2.98

MACD:

MACD(12,26): 0.06     Signal(12,26,9): 0.05

%K %D:

%K(14,3): 63.96     %D(3): 57.82

RSI:

RSI(14): 62.96

52-Week:

High: 4.07  Low: 2.2  Change(%): -19.0

Average Vol(K):

3-Month: 169203  10-Days 105561

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CLDX has closed above the upper band by 4.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 58.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLDX's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 16 Mar 2017 17:03:45 GMT
Traders Take Note: Celldex Therapeutics Inc (NASDAQ:CLDX) Stock Drops ...

Sun, 10 Dec 2017 14:31:38 GMT
Why Celldex Therapeutics Stock Reversed Course in November

Wed, 22 Nov 2017 11:16:39 GMT
Breakfast Technical Briefing on Biotech Stocks -- Calithera Biosciences ...

Wed, 29 Nov 2017 13:41:15 GMT
Here's Where Things Went Wrong for Celldex Therapeutics, Inc. in 2017

Mon, 04 Dec 2017 12:00:00 GMT
Few Things investors Didn't Know About: Celldex Therapeutics, Inc. (CLDX ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

135.98

Shares Float (M)

120.82

% Held by Insiders

0.62

% Held by Institutions

54.23

Shares Short (K)

13260

Shares Short Prior Month (K)

13720

Stock Financials

EPS

-1.090

EPS Est. Current Year

-1.040

EPS Est. Next Year

-0.950

EPS Est. Next Quarter

-0.280

Forward EPS

-0.909

Book Value (p.s.)

1.820

PEG Ratio

Profit Margin

Operating Margin

-1270.87

Return on Assets (ttm)

-24.3

Return on Equity (ttm)

-53.5

Qtrly Rev. Growth

175.7

Gross Profit (p.s.)

0.050

Sales Per Share

EBITDA (p.s.)

-0.847

Qtrly Earnings Growth

Operating Cash Flow (M)

-100.35

Levered Free Cash Flow (M)

-47.15

atoplab.com

Valuation

P/E

-2.78

P/E Growth Ratio

0.03

P/BV

1.66

P/S

5150242304.00

P/CF

-4.11

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.